Relx PLC (RELX)
Stock Price:
$22.38 USD
0.23 (1.04%)
Updated Aug 11, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
43.07B |
| Revenue (ttm) |
10.27B |
| Net Income (ttm) |
1.96B |
| Shares Out |
1.93B |
| EPS (ttm) |
1.09 |
| PE Ratio |
20.53 |
| Forward PE |
19.88 |
| Dividend |
$0.57 |
| Dividend Yield |
2.55% |
Stock Quote
| Trading Day |
Aug 11, 2020 |
| Last Price |
$22.38 |
| Previous Close |
$22.15 |
| Change ($) |
0.23 |
| Change (%) |
1.04% |
| Day's Open |
22.65 |
| Day's Range |
22.37 - 22.69 |
| Day's Volume |
662,185 |
| 52-Week Range |
16.81 - 27.25 |
More Stats
| Market Cap |
43.07B |
| Enterprise Value |
51.26B |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
Jul 31, 2020 |
| Shares Outstanding |
1.93B |
| Float |
1.91B |
| EPS (basic) |
n/a |
| EPS (diluted) |
1.09 |
| FCF / Share |
1.56 |
| Dividend |
$0.57 |
| Dividend Yield |
2.55% |
| Earnings Yield |
4.87% |
| FCF Yield |
7.11% |
| Payout Ratio |
n/a |
| Shares Short |
1.87M |
| Short Ratio |
1.36 |
| Short % of Float |
n/a |
| Beta |
0.24 |
| PE Ratio |
20.53 |
| Forward PE |
19.88 |
| P/FCF Ratio |
14.07 |
| PS Ratio |
4.19 |
| PB Ratio |
15.70 |
| Revenue |
10.27B |
| Operating Income |
2.69B |
| Net Income |
1.96B |
| Free Cash Flow |
3.06B |
| Net Cash |
-8.19B |
| Net Cash / Share |
-4.25 |
| Gross Margin |
65.01% |
| Operating Margin |
26.16% |
| Profit Margin |
19.10% |
| FCF Margin |
29.79% |
| ROA |
9.21% |
| ROE |
66.34% |
| ROIC |
n/a |
Key stats in USD, based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (4)
| Buy |
1 |
| Overweight |
0 |
| Hold |
3 |
| Underweight |
0 |
| Sell |
0 |
Analyst Consensus: Overweight
Price Target
$22.90*
(2.32% upside)
Low
18.5
Current: $22.38
High
27.3
Target: 22.90
*Average 12-month USD price target from 2 stock analysts.
Financial Performance
Financial numbers in millions GBP.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | 7,874 | 7,492 | 7,341 | 6,889 | 5,971 | 5,773 | 6,035 | 6,116 | 6,002 | 6,055 |
| Revenue Growth | 5.1% | 2.06% | 6.56% | 15.37% | 3.43% | -4.34% | -1.32% | 1.9% | -0.88% | - |
| Gross Profit | 5,119 | 4,848 | 4,713 | 4,401 | 3,842 | 3,767 | 3,917 | 3,977 | 3,876 | 3,846 |
| Operating Income | 2,060 | 1,932 | 1,868 | 1,671 | 1,433 | 1,366 | 1,347 | 1,309 | 1,141 | 1,068 |
| Net Income | 1,505 | 1,422 | 1,648 | 1,150 | 1,008 | 955 | 1,110 | 1,044 | 731 | 642 |
| Shares Outstanding | 1,962 | 2,124 | 2,164 | 2,224 | 1,907 | 2,005 | 1,988 | 1,979 | 1,977 | 1,975 |
| Earnings Per Share | 0.77 | 0.71 | 0.81 | 0.55 | 0.46 | 0.43 | 0.48 | - | - | - |
| EPS Growth | 7.7% | -11.85% | 46.47% | 20.22% | 8.24% | -12.01% | - | - | - | - |
| Dividend Per Share | 0.40 | 0.55 | 0.47 | 0.45 | 0.41 | 0.42 | 0.36 | 0.35 | 0.33 | 0.31 |
| Dividend Growth | -27.64% | 16.53% | 5.83% | 9.31% | -2.63% | 17.37% | 2.59% | 4.5% | 8.12% | - |
| Operating Cash Flow | 2,724 | 2,555 | 2,526 | 2,311 | 1,882 | 1,851 | 1,943 | 1,847 | 1,735 | 1,649 |
| Capital Expenditures | -378 | -358 | -353 | -332 | -306 | -260 | -302 | -326 | -343 | -304 |
| Free Cash Flow | 2,346 | 2,197 | 2,173 | 1,979 | 1,576 | 1,591 | 1,641 | 1,521 | 1,392 | 1,345 |
| Cash & Equivalents | 138 | 114 | 111 | 162 | 122 | 276 | 132 | 641 | 726 | 742 |
| Total Debt | 6,414 | 6,365 | 5,253 | 5,256 | 3,902 | 3,825 | 3,281 | 3,892 | 4,282 | 4,302 |
| Net Cash / Debt | -6,276 | -6,251 | -5,142 | -5,094 | -3,780 | -3,549 | -3,149 | -3,251 | -3,556 | -3,560 |
| Assets | 13,789 | 13,999 | 12,632 | 13,714 | 11,185 | 11,087 | 10,495 | 11,014 | 11,503 | 11,158 |
| Liabilities | 11,599 | 11,640 | 10,319 | 11,406 | 9,007 | 8,950 | 8,072 | 8,700 | 9,306 | 9,188 |
| Book Value | 2,166 | 2,329 | 2,292 | 2,270 | 2,144 | 2,106 | 2,390 | 2,280 | 2,172 | 1,943 |
Numbers in millions GBP, except per-share numbers.
Company Details
| Full Name |
Relx PLC |
| Country |
United Kingdom |
| Employees |
33,000 |
| CEO |
Erik Niklas Engstrom |
Stock Information
| Ticker Symbol |
RELX |
| Stock Exchange |
New York Stock Exchange |
| Unique Identifier |
NYSE: RELX |
Description
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Risk & Business Analytics segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as enhance the productivity. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.